Hong Kong’s Tech Resurgence

By Shayne Heffernan

Hong Kong’s stock exchange has staged a notable recovery and repositioning in 2026, fueled by a surge in specialist technology listings and renewed investor appetite for companies advancing artificial intelligence and related deep technologies. The first quarter alone saw HK$109.9 billion raised across 40 listings, the strongest opening in five years according to KPMG data, with nearly 80% coming from A+H and specialist technology deals. Overall IPO fundraising for the year is tracking toward HK$320–350 billion, per PwC forecasts, supported by a healthy pipeline that includes further AI and advanced tech names.

Market capitalization across HKEX reached HK$47.1 trillion by end-May, up 15% year-on-year, while average daily turnover strengthened. The Hang Seng Index has traded around the 24,700 level in mid-June amid some consolidation after earlier gains, yet major banks maintain constructive end-2026 targets clustered between 28,000 and 31,000. These projections rest on expected earnings growth, policy support for high-end manufacturing and technology, and Hong Kong’s role as a capital-raising venue for Chinese innovators navigating global constraints.

A defining feature of the current cycle is the wave of AI-related IPOs that began building momentum in late 2025 and accelerated into 2026. Twelve companies across the AI value chain listed in a short window around the turn of the year, raising several billion dollars. Foundational model developers, infrastructure plays, and application specialists have created a visible ecosystem on the exchange. This activity aligns with broader Chinese policy emphasis on “new quality productive forces” and technological self-reliance, while Hong Kong’s Chapter 18C listing route for specialist technology companies has proven attractive for pre-commercial or high-growth innovators.

Against this backdrop, five companies stand out for their direct involvement in AI, quantum technologies, or the intersection of computational breakthroughs and digital finance themes. Several also offer investors access through US-listed ADRs or OTC tickers, providing cross-border liquidity options alongside their primary Hong Kong listings.

Here is a summary of the key names and their trading venues:

Knowledge Atlas Technology (Zhipu AI, 02513.HK) represents one of the clearest expressions of China’s foundational model push. Spun out of Tsinghua University and backed by prominent investors including Meituan, Tencent, and Ant Group, the company develops the GLM series of large language models. It positions itself among China’s “AI tigers” and emphasizes open-source strategies alongside commercial agent and coding capabilities. The January 2026 listing raised approximately HK$4.35 billion at an offer price of HK$116.20, implying an initial valuation near HK$51 billion. Shares saw strong debut gains and further rallies on subsequent model releases, including GLM-5 updates that highlighted improved coding and long-running agent performance. Market capitalization expanded rapidly in the following months as investors priced in commercial traction and the broader enthusiasm for domestic AI champions.

Zhipu’s trajectory underscores both opportunity and execution risk. Revenue remains modest relative to valuation, typical of early-stage foundational model companies, yet partnerships and platform adoption provide pathways to monetization. Competition from both domestic peers and global leaders remains intense, while access to advanced training and inference hardware continues to shape development timelines. For HKEX, Zhipu’s listing helped validate the exchange as a credible home for high-profile AI names and contributed to the visible re-rating of the technology segment.

MiniMax Group (0100.HK, also trading OTC in the US as MNMXF) followed a similar path as another member of the “AI tigers” cohort. Founded in 2021 by former SenseTime executives, the company has focused on building unified models capable of handling text, speech, and video, with consumer-facing applications such as the Hailuo AI video generator gaining attention. Its January 2026 IPO priced at the upper end of the range and delivered a dramatic first-day performance, closing more than 100% above the HK$165 offer price. The raise totaled several hundred million dollars and pushed initial market capitalization well above HK$100 billion at peaks.

Subsequent trading has shown the volatility common to newly listed growth names, with prices moving between the low 200s and highs above 1,300 HKD in the months after debut. This price action reflects both genuine excitement about multimodal capabilities and the market’s ongoing assessment of commercialization progress and competitive positioning. MiniMax’s emphasis on practical product deployment alongside frontier research differentiates it within the cohort and aligns with investor interest in companies that can translate model performance into user engagement or enterprise use cases. The availability of the MNMXF OTC line in the US gives international investors an additional entry point without needing a Hong Kong brokerage account.

Tencent Holdings (0700.HK / TCEHY) provides scale and distribution that pure-play model developers lack. The company has invested heavily in its Hunyuan large language model family and integrated AI capabilities across WeChat, cloud services, and gaming platforms. Enterprise adoption of Hunyuan for summarization, content generation, and workflow tools has progressed, while Tencent Cloud continues to expand AI infrastructure offerings. The gaming business, long a core profit engine, faces cyclical pressures but also serves as a testbed for AI-driven features and personalization.

Tencent’s balance sheet strength and existing user base of over a billion WeChat accounts give it multiple levers for AI monetization that smaller specialists cannot match. At the same time, the stock has at times lagged the sharpest moves in pure AI names, reflecting its conglomerate nature and the market’s occasional preference for focused exposure. The dual listing via TCEHY in the US provides deep liquidity for global investors and remains a bellwether holding whose AI progress influences broader sentiment toward the Hong Kong technology complex.

Alibaba Group Holding (9988.HK / BABA) similarly combines infrastructure and application layers. Alibaba Cloud has positioned itself as a key provider of AI compute and tooling, while the Qwen model family has earned recognition for strong performance in mathematical reasoning and coding benchmarks. Internal AI deployments across e-commerce logistics, recommendation systems, and customer service have delivered measurable efficiency gains, and the company has signaled substantial multi-year capex commitments to cloud and AI capacity.

Alibaba’s scale in consumer and enterprise China gives it immediate pathways to embed AI that many startups must still build. Cloud revenue growth and AI-related attach rates remain key metrics for investors evaluating the re-rating potential. The NYSE-listed BABA shares offer one of the most liquid US entry points among Chinese technology names, complementing the Hong Kong listing and allowing investors to express views on Alibaba’s AI infrastructure story through either venue.

XtalPi Holdings (2228.HK / QNTPF) brings the quantum dimension into focus. Founded in 2015 by MIT-trained physicists and formerly known as QuantumPharm, the company combines quantum physics-based simulation, artificial intelligence, and robotic automation to accelerate drug discovery and materials R&D. Its hybrid AI + quantum mechanics engine aims to generate scalable first-principles data that reduces reliance on large experimental datasets, a potential advantage in early-stage discovery where data scarcity often limits pure AI approaches. The June 2024 listing under Chapter 18C marked the first use of Hong Kong’s specialized technology route and raised roughly HK$990 million.

Clients include global pharmaceutical companies such as Pfizer and Johnson & Johnson, alongside domestic partners. Post-listing, the company has continued platform development, including intelligent synthesis workstations and generative chemistry tools. While still pre-profit and subject to the long timelines typical of drug discovery platforms, XtalPi demonstrates Hong Kong’s willingness to host genuinely frontier technology companies that blend quantum methods with AI. The QNTPF OTC line in the US extends access for American investors interested in this quantum-AI hybrid approach to life sciences.

These five names do not exhaust the AI and quantum activity on HKEX—chip designers such as Iluvatar CoreX and Biren Technology, established players like SenseTime, and a broader pipeline of application specialists have also contributed to the ecosystem. Together they signal a structural shift: Hong Kong is successfully attracting listings across the AI stack at a moment when Chinese technology firms seek diversified capital access. The presence of US ADR or OTC lines for four of the five names adds another layer of accessibility and liquidity that many pure Hong Kong listings lack.

Bitcoin and broader digital asset themes intersect this story more indirectly but remain relevant to the overall sentiment environment. Hong Kong has developed Bitcoin reference indices and authorized virtual asset ETFs, positioning itself as Asia’s leading digital assets hub. Globally, corporate treasury strategies exemplified by Strategy (formerly MicroStrategy) under Michael Saylor have highlighted Bitcoin’s role as a scarce asset in an environment of expansive monetary policies. While few pure-play Bitcoin mining or holding companies rank among HKEX’s largest technology constituents, the exchange’s infrastructure for virtual assets complements its technology listings by offering investors multiple vectors of exposure to monetary innovation and computational breakthroughs. In periods of abundant liquidity and shifting reserve asset preferences, capital has historically rotated toward both categories.

Looking forward, the outlook for these companies and the broader HKEX technology segment rests on several variables. Continued policy support in China for AI and advanced manufacturing provides a tailwind, as does Hong Kong’s regulatory clarity on specialist listings. Commercial traction—measured in revenue ramp for the newer AI names, cloud attach rates for the giants, and milestone progress or partnership expansion for XtalPi—will determine whether current valuations prove sustainable or require recalibration. Hardware access constraints and intensifying domestic and international competition represent ongoing risks, particularly for foundational model developers still scaling toward consistent profitability.

Analyst targets for the Hang Seng Index through year-end imply meaningful upside from mid-2026 levels, predicated on earnings delivery and some multiple support from technology leadership. Realization of that upside will likely depend on a steady IPO pipeline, visible progress from the AI cohort on monetization, and a macro backdrop that remains supportive of risk assets. Geopolitical tensions and any shifts in global liquidity conditions could introduce volatility, yet the structural drivers—China’s technological priorities, Hong Kong’s capital markets franchise, and genuine innovation in AI and quantum methods—appear durable.

For investors, the current environment on HKEX offers exposure to both established platforms with distribution advantages and newer specialists capturing frontier capabilities. The five companies highlighted here encapsulate much of that spectrum, with the added benefit of US ADR or OTC access for most. Their individual trajectories will help define whether 2026 marks a durable re-rating for Hong Kong’s technology franchise or another cyclical swing. Early evidence from listing volumes, debut performance, and model release momentum suggests the former remains the base case for many market participants.

The exchange’s ability to host this mix of companies efficiently, transparently, and with access to diverse capital pools continues to differentiate it. As AI moves from research to deployment and quantum methods find practical applications in discovery workflows, Hong Kong’s market infrastructure appears well placed to intermediate the next phase of that transition—whether investors access the names through their Hong Kong listings or the corresponding US tickers.